<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Cambria;
panose-1:2 4 5 3 5 4 6 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
mso-add-space:auto;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
mso-add-space:auto;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
mso-add-space:auto;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
mso-add-space:auto;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1931888991;
mso-list-type:hybrid;
mso-list-template-ids:508185614 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal" style="margin-bottom:8.0pt;background:white"><span style="font-family:"Cambria",serif;color:black">Dear EIC Project Team, <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom:8.0pt;background:white"><span style="font-family:"Cambria",serif;color:black">Good news! I am happy to report that the slower than planned ramp up of the EIC start-up phase is resolved by the Inflation Reduction Act
(IRA) funding. We are restoring our momentum and remain committed to expeditiously achieving the upcoming DOE Critical Decision (CD) milestones. We continue to plan according to our Reference Funding Profile Version 3’ (V3 plus IRA), which assumes $90M in
the FY2023 annual appropriation and subsequently ramping up to $300M per year by FY2026.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom:8.0pt;background:white"><span style="font-family:"Cambria",serif;color:black">We are preparing for a major DOE status review scheduled for January 31 – February 2, 2023. The primary focus of this review is to provide
an update on status since CD-1 and our plans to achieve CD-3a, CD-2, and CD-3. In consideration of our current status and the funding plans, we are making an adjustment to our CD plans as described below: <o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraphCxSpFirst" style="color:black;margin-bottom:8.0pt;margin-left:0in;mso-add-space:auto;mso-list:l0 level1 lfo1;background:white">
<span style="font-family:"Cambria",serif">CD-3a, Long Lead Procurement Approval = No Change. DOE review in October 2023 and DOE approval of CD-3a in January 2024. <o:p></o:p></span></li><li class="MsoListParagraphCxSpMiddle" style="color:black;margin-bottom:8.0pt;margin-left:0in;mso-add-space:auto;mso-list:l0 level1 lfo1;background:white">
<span style="font-family:"Cambria",serif">CD-2, Performance Baseline Approval = Revised. DOE review in October 2024 and CD-2 approval in January 2025. <o:p></o:p></span></li><li class="MsoListParagraphCxSpLast" style="color:black;margin-bottom:8.0pt;margin-left:0in;mso-add-space:auto;mso-list:l0 level1 lfo1;background:white">
<span style="font-family:"Cambria",serif">CD-3, Start of Construction Approval = No Change. DOE review TBD and CD-3 approval in April 2025 prior to RHIC Shutdown in June 2025. <o:p></o:p></span></li></ul>
<p class="MsoNormal" style="margin-bottom:8.0pt;background:white"><span style="font-family:"Cambria",serif;color:black">After consultation with DOE, we are accepting a later date for CD-2 given the limited people resources available and our priority on completing
preliminary and final design of CD-3a Long Lead Procurement items. This schedule acknowledges slower than planned progress in the last two years including: ramp-up of staff, execution of contracts, securing international partners, and a delay in securing
the $100M of New York State funding for an EIC Infrastructure Project. <o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom:8.0pt;background:white"><span style="font-family:"Cambria",serif;color:black">We will continue to manage to our preliminary baseline, using formal change control and EVMS starting in July 2023. This is essential in
order to maintain the CD-3a approval date as it drives the overall schedule and requires a clear understanding of the baseline technical scope.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom:8.0pt;background:white"><span style="font-family:"Cambria",serif;color:black">There are important details to work out concerning the sequence of activities, particularly reviews after CD-2 approval and prior to CD-3
approval. Plans for the CD approvals in 2025 will continue to develop as we discuss the details with DOE. Please continue to hire, partner, collaborate, and define in-kind deliverables /institutions. The pace of the project will be determined by our ability
to grow the effort dedicated to project activities and schedule performance.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom:8.0pt;background:white"><span style="font-family:"Cambria",serif;color:black">Best wishes for this Thanksgiving holiday break!
<o:p></o:p></span></p>
<p class="MsoNormal" style="background:white"><span style="font-family:"Cambria",serif;color:black">Sincerely, <o:p></o:p></span></p>
<p class="MsoNormal" style="background:white"><span style="font-family:"Cambria",serif;color:black">Jim<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:black">Jim Yeck</span><span style="font-family:"Cambria",serif"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:black">EIC Project Director</span><span style="font-size:10.0pt;font-family:"Cambria",serif"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:black">Electron-Ion Collider</span><span style="font-family:"Cambria",serif"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:black">Brookhaven National Laboratory</span><span style="font-family:"Cambria",serif"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Cambria",serif;color:black">C: (608) 999-1740</span><span style="font-family:"Cambria",serif"><o:p></o:p></span></p>
<p class="MsoNormal"><i><span style="font-family:"Cambria",serif;color:black">Alyssa Petrone, Assistant, <a href="mailto:apetrone@bnl.gov"><span style="color:#954F72">apetrone@bnl.gov</span></a></span></i><span style="font-family:"Cambria",serif"><o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>